NORGES BANK

Bank

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1374170 OSLO, Q8

Position in AMRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,797,814

-$7,409,886 QoQ

Shares Held

219,400

-75.3% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#79

of 311 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. AMRX ranks #14 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	32,299,753	$1,094,315,631
2	UTHR	UNITED THERAPEUTICS Corp	694,753	$376,438,017
3	ZTS	Zoetis Inc.	4,689,847	$337,012,405
4	NBIX	Neurocrine Biosciences Inc	973,880	$164,137,735
5	ALKS	Alkermes plc.	2,156,814	$113,017,053
6	HLN	Haleon plc	7,175,000	$66,942,750
7	LNTH	Lantheus Holdings, Inc.	586,845	$65,104,584
8	VTRS	Viatris Inc	3,822,744	$60,705,174

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,797,814	219,400	-75.3%	Shares	Sole	2026-08-12
2025-12-31	$11,207,700	889,500	+931.9%	Shares	Sole	2026-02-10
2024-06-30	$547,370	86,200	+21.2%	Shares	Sole	2024-08-14
2023-03-31	$98,829	71,100	-97.4%	Shares	Sole	2024-05-15
2022-12-31	$5,401,656	2,714,400	+518.0%	Shares	Sole	2023-02-14
2022-03-31	$1,831,701	439,257	-35.5%	Shares	Sole	2023-05-12
2021-12-31	$3,260,596	680,709	-10.6%	Shares	Sole	2022-03-09
2021-09-30	$4,065,091	761,253	0.0%	Shares	Sole	2022-11-14
2021-06-30	$3,897,615	761,253	-5.8%	Shares	Sole	2022-08-15
2021-03-31	$5,437,207	807,906	-26.1%	Shares	Sole	2022-05-09
2020-12-31	$4,999,369	1,093,954	0.0%	Shares	Sole	2021-03-02
2020-09-30	$4,244,541	1,093,954	+2.4%	Shares	Sole	2021-11-12
2020-06-30	$5,084,893	1,068,255	-5.3%	Shares	Sole	2021-08-13
2020-03-31	$3,923,713	1,127,504	—	Shares	Sole	2021-05-07
No filing history on record for this holder in this stock.